Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether specific subcutaneous immunotherapy affects
fractions of regulatory T lymphocytes and histamine H2 receptor expression and ZAP70 in
regulatory T lymphocytes.